Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -20 | 9 | 31 | -14 | -26 |
| Other Working Capital | -38 | 512 | 453 | 423 | -215 |
| Other Operating Activity | -2,067 | -1,692 | -1,313 | -947 | -594 |
| Operating Cash Flow | $-2,124 | $-1,172 | $-830 | $-539 | $-835 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,812 | 0 | 0 | 254 | 7 |
| Financing Cash Flow | $3,812 | $0 | $0 | $254 | $7 |
| Exchange Rate Effect | -29 | 1 | -4 | -14 | 5 |
| Beginning Cash Position | 1,843 | 3,014 | 3,848 | 4,147 | 4,970 |
| End Cash Position | 3,502 | 1,843 | 3,014 | 3,848 | 4,147 |
| Net Cash Flow | $1,688 | $-1,172 | $-830 | $-285 | $-828 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,124 | -1,172 | -830 | -539 | -835 |
| Free Cash Flow | -2,124 | -1,172 | -830 | -539 | -835 |